Longeveron Inc. (NASDAQ: LGVN) Stock Information | RedChip

Longeveron Inc. (NASDAQ: LGVN) Listen to this Section


$2.34
-0.1200 ( -4.88% ) 573.3K

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Market Data


Open


$2.34

Previous close


$2.46

Volume


573.3K

Market cap


$33.74M

Day range


$2.31 - $2.48

52 week range


$0.77 - $35.60

Insider Ownership Transactions

Total Amount Purchased: 67,496.00 | $ 157,940.64

Date Type Amount Purchased Purchaser
2024-08-07 Sale -16000.00 Hajjar Roger Joseph
2024-08-07 Sale -16000.00 Motwani Neha J.
2024-07-03 Sale -357.00 Locklear Lisa
2024-06-11 Sale -125.00 Baluch Khoso
2024-06-07 Sale -325.00 Lehr Paul T
2024-05-14 Sale -16000.00 Kender Richard N
2024-05-06 Sale -410.00 Locklear Lisa
2024-05-06 Sale -308.00 Agafonova Nataliya
2024-04-12 Buy 10638.00 Hashad Mohamed Wa'el Ahmed
2024-04-12 Buy 106383.00 Soffer Rock

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 14, 2024
10-q Quarterly Reports 73 Aug 14, 2024
4 Insider transactions 1 Aug 07, 2024
3 Insider transactions 2 Aug 07, 2024
4 Insider transactions 1 Aug 07, 2024
3 Insider transactions 2 Aug 07, 2024
8-k 8K-related 19 Jul 19, 2024
8-k 8K-related 15 Jul 17, 2024
8-k 8K-related 15 Jul 10, 2024
4 Insider transactions 1 Jul 03, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.